Edwards Lifesciences Corporation (EW)
Company Info
Highlights
$43.72B
$2.59
28.62
6.79
$5.87B
$4.57B
$1.70B
$58.93 - $96.12
$79.23
1.47%
1.80
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Edwards Lifesciences Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Edwards Lifesciences Corporation had a return of -3.04% year-to-date (YTD) and -0.26% in the last 12 months. Over the past 10 years, Edwards Lifesciences Corporation had an annualized return of 12.87%, outperforming the S&P 500 benchmark which had an annualized return of 10.96%.
EW
-3.04%
5.31%
-16.78%
-0.26%
-1.27%
12.87%
^GSPC (Benchmark)
23.00%
-0.84%
7.20%
24.88%
12.77%
10.96%
Monthly Returns
The table below presents the monthly returns of EW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.91% | 8.16% | 12.60% | -11.40% | 2.62% | 6.31% | -31.74% | 10.96% | -5.67% | 1.55% | 6.48% | -3.04% | |
| 2023 | 2.80% | 4.88% | 2.85% | 6.35% | -4.26% | 11.99% | -13.00% | -6.82% | -9.40% | -8.03% | 6.26% | 12.61% | 2.20% |
| 2022 | -15.71% | 2.90% | 4.76% | -10.14% | -4.66% | -5.71% | 5.73% | -10.38% | -8.29% | -12.34% | 6.65% | -3.42% | -42.41% |
| 2021 | -9.48% | 0.63% | 0.65% | 14.20% | 0.40% | 8.00% | 8.40% | 4.37% | -3.39% | 5.84% | -10.44% | 20.73% | 42.00% |
| 2020 | -5.76% | -6.83% | -7.92% | 15.31% | 3.32% | -7.74% | 13.46% | 9.48% | -7.01% | -10.19% | 17.02% | 8.75% | 17.32% |
| 2019 | 11.26% | -0.66% | 13.02% | -7.98% | -3.05% | 8.22% | 15.22% | 4.22% | -0.87% | 8.40% | 2.75% | -4.76% | 52.31% |
| 2018 | 12.31% | 5.60% | 4.38% | -8.72% | 7.81% | 6.02% | -2.14% | 1.26% | 20.70% | -15.22% | 9.76% | -5.46% | 35.90% |
| 2017 | 2.71% | -2.29% | 0.03% | 16.58% | 4.92% | 2.75% | -2.59% | -1.32% | -3.83% | -6.48% | 14.64% | -3.83% | 20.29% |
| 2016 | -0.98% | 11.24% | 1.39% | 20.41% | -7.26% | 1.25% | 14.83% | 0.56% | 4.69% | -21.02% | -12.99% | 13.10% | 18.64% |
| 2015 | -1.59% | 6.12% | 7.10% | -11.10% | 3.21% | 8.96% | 6.83% | -7.41% | 0.92% | 10.54% | 3.72% | -3.09% | 24.01% |
| 2014 | -0.97% | 7.13% | 6.32% | 9.84% | -0.33% | 5.71% | 5.14% | 9.98% | 2.91% | 18.37% | 7.24% | -1.77% | 93.70% |
| 2013 | -0.27% | -4.45% | -4.39% | -22.36% | 4.19% | 1.11% | 6.22% | -1.40% | -1.07% | -6.38% | 0.52% | 0.35% | -27.07% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of EW is 45, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Edwards Lifesciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Edwards Lifesciences Corporation was 54.32%, occurring on Jul 25, 2024. The portfolio has not yet recovered.
The current Edwards Lifesciences Corporation drawdown is 43.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -54.32% | Dec 31, 2021 | 644 | Jul 25, 2024 | — | — | — |
| -50.48% | Sep 1, 2000 | 43 | Nov 1, 2000 | 165 | Jun 29, 2001 | 208 |
| -44.02% | Oct 5, 2012 | 299 | Dec 13, 2013 | 217 | Oct 24, 2014 | 516 |
| -37.11% | Feb 12, 2002 | 112 | Jul 23, 2002 | 199 | May 7, 2003 | 311 |
| -36.15% | Nov 29, 2019 | 78 | Mar 23, 2020 | 110 | Aug 27, 2020 | 188 |
Volatility
Volatility Chart
The current Edwards Lifesciences Corporation volatility is 8.18%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Edwards Lifesciences Corporation compared to its peers in the Medical Devices industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for EW in comparison to other companies of the Medical Devices industry. Currently, EW has a PE value of 28.6. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for EW in comparison to other companies of the Medical Devices industry. Currently, EW has a PEG value of 6.8. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Edwards Lifesciences Corporation.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |